Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)

✍ Scribed by Aminah Jatoi; Shaker R. Dakhil; Jeff A. Sloan; John W. Kugler; Kendrith M. Rowland; Paul L. Schaefer; Paul J. Novotny; Donald B. Wender; Howard M. Gross; Charles L. Loprinzi

• Book ID: 106174550
• Publisher: Springer-Verlag
• Year: 2010
• Tongue: English
• Weight: 257 KB
• Volume: 19
• Category: Article
• ISSN: 0941-4355
• DOI: 10.1007/s00520-010-0988-5